30 Capsules • USA Crafted • 60-Day Guarantee
GLPro – daily metabolic and blood-sugar wellness support
GLPro is marketed as a once-daily metabolic-support supplement for adults interested in healthy glucose patterns, appetite control and everyday energy. The current sales page does not publish a full readable label in text, and an FDA advisory letter issued May 1, 2026 objected to disease-treatment claims used in GLPro marketing, so this page keeps its positioning strictly in the dietary-supplement wellness lane.
- 30 capsules per bottle shown on current seller artwork
- 2-, 3- and 6-bottle packages currently offered
- 60-day seller money-back guarantee
- FDA advisory context disclosed prominently
GLPro at a glance
What GLPro is built to support
GLPro is marketed as a once-daily metabolic-support supplement for adults interested in healthy glucose patterns, appetite control and everyday energy. The current sales page does not publish a full readable label in text, and an FDA advisory letter issued May 1, 2026 objected to disease-treatment claims used in GLPro marketing, so this page keeps its positioning strictly in the dietary-supplement wellness lane.
How the formula is intended to work
The current tryglpro.com sales page does not expose a complete Supplement Facts panel in accessible text. A May 2026 independent label audit reported 11 actives and amounts from a panel then hosted at tryglpro.com; those values are included here as a reported label transcription and should be rechecked against the bottle received because GLPro-branded pages online list conflicting formulas.
GLPro ingredients & declared dosages
| Ingredient | Declared amount | Manufacturer / label context | Evidence / potential role |
|---|---|---|---|
| Riboflavin (Vitamin B2) | 25 mg (reported May 2026 label transcription) | Reported label amount; current seller text does not expose panel | Riboflavin is an essential vitamin involved in energy metabolism; its presence does not establish a glucose-lowering effect for GLPro. [label-audit] |
| Mangosteen powder | 100 mg (reported) | Reported label transcription | Human evidence for metabolic outcomes from this dose in GLPro is not established. [label-audit] |
| Prickly pear extract 4:1 | 100 mg (reported) | Reported label transcription | Ingredient-level metabolic research does not establish finished-product efficacy. [label-audit] |
| Cinnamon bark extract 10:1 | 100 mg (reported) | Reported label transcription | NCCIH says cinnamon research for diabetes is difficult to interpret and does not clearly support using cinnamon for any health condition. [label-audit][nccih-cinnamon] |
| Konjac extract fiber / glucomannan | 50 mg (reported) | Reported label transcription; source described 90% glucomannan | Research cited by NIH typically evaluates glucomannan in gram-level daily doses, so a 50 mg extract cannot be assumed equivalent to studied regimens. [label-audit][ods-glucomannan] |
| Alpha-lipoic acid | 25 mg (reported) | Reported label transcription | NCCIH notes weak evidence that alpha-lipoic acid may help diabetic neuropathy pain, but that does not establish GLPro's metabolic claims. [nccih-diabetes] |
| Turmeric extract (95% curcumin reported) | 15 mg (reported) | Reported label transcription | Turmeric has safety considerations including rare liver injury reports in some enhanced-bioavailability products; no finished GLPro trial was identified. [label-audit][nccih-turmeric] |
| Berberine HCl | 15 mg (reported) | Reported label transcription | Berberine meta-analyses most often involve about 0.9–1.5 g/day—far above this reported 15 mg amount—so study results should not be mapped directly onto GLPro. [label-audit][berberine-meta] |
| Resveratrol extract | 12 mg (reported) | Reported label transcription | This dose is reported by the label audit; no GLPro-specific clinical trial was identified. [label-audit] |
| Bifidobacterium breve | 1 billion CFU (reported) | Reported label transcription | Probiotic effects are strain-specific and do not establish blood-glucose control for the finished formula. [label-audit] |
| Akkermansia muciniphila | 1 billion CFU (reported) | Reported label transcription | The current seller page does not expose a complete panel in text; verify the actual bottle label before relying on this amount. [label-audit] |
GLPro price & package options
Package pricing is shown only when it has a dated commercial source. Seller pricing can change without notice.
2 Bottles
2 Bottles
60-day supply
$79 / bottle
Total $158
Shipping charged on current offer
View 2-Bottle OfferVerified 2026-10-23 · Current tryglpro.com offer checked 2026-10-23.
3 Bottles
3 Bottles
90-day supply
$69 / bottle
Total $207
Shipping charged on current offer
View 3-Bottle OfferVerified 2026-10-23 · Current tryglpro.com offer checked 2026-10-23.
6 Bottles
6 Bottles
180-day supply
$49 / bottle
Total $294
Seller marks this Best Value
Free U.S. shipping shown
View Best-Value OfferVerified 2026-10-23 · Current tryglpro.com offer checked 2026-10-23.
Where to buy GLPro
GLPro is sold through the current BuyGoods-backed seller checkout at tryglpro.com. This publication is independent. Because the FDA issued an advisory letter regarding disease-treatment claims used in GLPro marketing, buyers should evaluate the actual label and use the product only as a dietary supplement, not as a substitute for diabetes diagnosis or treatment.
Current tryglpro.com offer checked October 23, 2026.
Safety, interactions & who should be cautious
- If you have diabetes or use insulin or glucose-lowering medicines, discuss supplements with your clinician. NCCIH notes that supplements such as berberine or cinnamon may affect blood sugar and that combining supplements with diabetes drugs can cause unwanted effects. [nccih-diabetes]
- The FDA advisory letter is specifically about disease-treatment claims used in GLPro marketing. Do not use GLPro as a replacement for prescribed diabetes treatment, glucose monitoring or medical care. [fda-advisory]
- Glucomannan can cause gastrointestinal effects, and NIH describes obstruction reports with some tablet forms. The reported GLPro amount is small, but label verification and adequate water remain important. [ods-glucomannan][label-audit]
- NCCIH reports gastrointestinal side effects with turmeric and rare liver injury reports with some high-bioavailability curcumin formulations. The exact form used in GLPro should be checked on the bottle label. [nccih-turmeric][label-audit]
What the evidence says
| Claim / question | Evidence assessment | Strength |
|---|---|---|
| What did the FDA say about GLPro in 2026? | On May 1, 2026, the FDA issued Online Advisory Letter #726911 after reviewing GLPro websites and stated that claims used to promote GLPro Blood Sugar Support and GLPro+ established intended uses to treat or prevent diabetes, causing the products to be treated as unapproved drugs under the law. This is a regulatory issue about disease-treatment claims, not proof that the product is unsafe or ineffective, but it is highly relevant to how GLPro should be described. [fda-advisory] | strong |
| Does the reported berberine amount match clinical research doses? | No. A recent meta-analysis reported that the most common berberine doses in randomized trials were about 0.9–1.5 grams per day. The reported GLPro label transcription lists 15 mg of berberine HCl per serving, roughly two orders of magnitude lower, so trial results cannot be transferred directly to GLPro. [label-audit][berberine-meta] | moderate |
| What does cinnamon evidence show? | NCCIH says cinnamon studies for diabetes have conflicting and difficult-to-interpret results and that research does not clearly support cinnamon for any health condition. A 100 mg reported extract amount also cannot be assumed equivalent to the preparations studied in trials. [nccih-cinnamon][label-audit] | mixed |
| Is the finished GLPro formula clinically proven? | No product-specific randomized clinical trial of the current GLPro formula was identified. The current seller page also does not expose a readable full label in text, while different GLPro-branded pages online list conflicting ingredient sets. Finished-product efficacy therefore remains unestablished. [seller][label-audit][fda-advisory] | not established |
Potential strengths
- Current package pricing is clear
- Seller offers a 60-day refund window
- Reported panel provides more dose detail than many competing metabolic formulas
Important limitations
- FDA issued a 2026 advisory letter regarding disease-treatment claims used in GLPro marketing
- Current seller page does not expose a complete Supplement Facts panel in accessible text
- Reported berberine and glucomannan amounts are far below common research doses
- No finished-product randomized trial identified
How should GLPro be evaluated?
GLPro deserves a more cautious treatment than a typical affiliate blood-sugar page. The current seller offer is clear about packages, origin claims and a 60-day guarantee, but the complete label is not exposed in accessible text and GLPro-branded pages online disagree about the formula. More importantly, FDA Online Advisory Letter #726911 dated May 1, 2026 objected to claims that positioned GLPro products for treating or preventing diabetes. Our view is therefore narrow: assess the actual bottle label, keep expectations at general nutritional support, and do not infer clinical benefit from ingredient studies—especially when reported GLPro doses such as 15 mg berberine and 50 mg konjac extract are far below gram-level doses common in research.
Frequently asked questions about GLPro
What is GLPro?
GLPro is a dietary supplement marketed for general blood-sugar, appetite and metabolic wellness support. It is not an approved diabetes treatment.
Did the FDA issue a letter about GLPro?
Yes. On May 1, 2026 the FDA issued Online Advisory Letter #726911 concerning disease-treatment claims used on GLPro websites. The letter addresses regulatory claims and intended use, not a finding that every ingredient is unsafe.
What ingredients are in GLPro?
The current seller text does not expose a full readable panel. A May 2026 independent label transcription reported riboflavin, mangosteen, prickly pear, cinnamon, konjac/glucomannan, alpha-lipoic acid, turmeric, berberine, resveratrol, Bifidobacterium breve and Akkermansia muciniphila. Check the bottle you receive because online GLPro formulas conflict.
How much does GLPro cost?
On October 23, 2026 the seller page showed 2 bottles for $158, 3 bottles for $207 and 6 bottles for $294, with the six-bottle option at $49 per bottle and free U.S. shipping.
Is GLPro clinically proven?
No randomized clinical trial of the complete current GLPro formula was identified. Ingredient studies do not prove the finished product works.
Can GLPro replace diabetes medication?
No. Do not stop or change prescribed diabetes treatment because of supplement marketing. Discuss supplements with the clinician managing your glucose.
What is the GLPro guarantee?
The current seller page advertises a 60-day 100% money-back guarantee. Confirm current refund instructions at checkout.
References
- GLPro current seller page and package offer — GLPro. Source
Primary source for current package pricing, seller positioning and guarantee.
- GLPro - Online Advisory Letter, Reference #726911 — U.S. Food and Drug Administration (2026-05-01). Source
FDA letter addressing disease-treatment claims used on GLPro websites.
- GLPro Review 2026: verified Supplement Facts transcription — UT Cardiothoracic Surgery website (2026). Source
Secondary source that reports a May 2026 transcription of a GLPro Supplement Facts panel then hosted at tryglpro.com. Recheck against the bottle received.
- Diabetes and Dietary Supplements: What You Need To Know — NCCIH. Source
Evidence and safety context for supplements marketed around diabetes.
- Effects of administering berberine alone or in combination on type 2 diabetes mellitus: systematic review and meta-analysis — PubMed (2024). Source
Provides common studied berberine dose range and clinical evidence context.
- Dietary Supplements for Weight Loss - Health Professional Fact Sheet — NIH Office of Dietary Supplements. Source
Glucomannan dose, efficacy and safety context.
- Cinnamon: Usefulness and Safety — NCCIH. Source
Cinnamon evidence and safety context.
- Turmeric: Usefulness and Safety — NCCIH. Source
Turmeric/curcumin safety context.
- Information for Consumers on Using Dietary Supplements — FDA. Source
Change history
- — Created evidence-reviewed GLPro profile with current packages, FDA advisory context, reported-label dose comparison and product-specific header/order routing.
- — Expanded manufacturer-declared ingredient rows and authoritative evidence references; refreshed page freshness metadata after the material content update.